These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 30939950)
1. The preparation, characterization of Lupeol PEGylated liposome and its functional evaluation Zhang J; Liang H; Yao H; Qiu Z; Chen X; Hu X; Hu J; Zheng G Drug Dev Ind Pharm; 2019 Jul; 45(7):1052-1060. PubMed ID: 30939950 [No Abstract] [Full Text] [Related]
2. Zhang J; Hu X; Zheng G; Yao H; Liang H Drug Deliv; 2021 Dec; 28(1):709-718. PubMed ID: 33825591 [TBL] [Abstract][Full Text] [Related]
3. Preparation, Characterization, and In Vitro Pharmacodynamics and Pharmacokinetics Evaluation of PEGylated Urolithin A Liposomes. Yi S; Zhang C; Hu J; Meng Y; Chen L; Yu H; Li S; Wang G; Zheng G; Qiu Z AAPS PharmSciTech; 2021 Jan; 22(1):26. PubMed ID: 33404864 [TBL] [Abstract][Full Text] [Related]
4. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation. Shaji J; Menon I Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699 [TBL] [Abstract][Full Text] [Related]
5. Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes. Yuan J; Zhou X; Cao W; Bi L; Zhang Y; Yang Q; Wang S Nanoscale Res Lett; 2017 Nov; 12(1):585. PubMed ID: 29124481 [TBL] [Abstract][Full Text] [Related]
6. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats. Dadashzadeh S; Vali AM; Rezaie M Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511 [TBL] [Abstract][Full Text] [Related]
7. Preparation, optimization, and characterization of topotecan loaded PEGylated liposomes using factorial design. Vali AM; Toliyat T; Shafaghi B; Dadashzadeh S Drug Dev Ind Pharm; 2008 Jan; 34(1):10-23. PubMed ID: 18214751 [TBL] [Abstract][Full Text] [Related]
8. Enhanced Pharmacokinetics of Celastrol via Long-Circulating Liposomal Delivery for Intravenous Administration. Wang B; Shen J; Zhou C; Wang X; Wang S; Hou R Int J Nanomedicine; 2024; 19():5707-5718. PubMed ID: 38882540 [TBL] [Abstract][Full Text] [Related]
9. PEGylated niosomes-mediated drug delivery systems for Paeonol: preparation, pharmacokinetics studies and synergistic anti-tumor effects with 5-FU. He RX; Ye X; Li R; Chen W; Ge T; Huang TQ; Nie XJ; Chen HJ; Peng DY; Chen WD J Liposome Res; 2017 Jun; 27(2):161-170. PubMed ID: 27184460 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome. Yang G; Yang T; Zhang W; Lu M; Ma X; Xiang G J Agric Food Chem; 2014 Mar; 62(10):2207-15. PubMed ID: 24528163 [TBL] [Abstract][Full Text] [Related]
11. The characterization, pharmacokinetic, and tissue distribution studies of TPGS-modified artesunate liposome in rats. Hu C; Liang K; An R; Wang X; You L Drug Dev Ind Pharm; 2018 Sep; 44(9):1528-1535. PubMed ID: 29862854 [TBL] [Abstract][Full Text] [Related]
12. PEGylated liposomes as delivery systems for Gambogenic acid: Characterization and in vitro/in vivo evaluation. Tang X; Sun J; Ge T; Zhang K; Gui Q; Zhang S; Chen W Colloids Surf B Biointerfaces; 2018 Dec; 172():26-36. PubMed ID: 30125771 [TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization, pharmacokinetics and anticancer effects of PEGylated β-elemene liposomes. Zhai B; Wu Q; Wang W; Zhang M; Han X; Li Q; Chen P; Chen X; Huang X; Li G; Zhang Q; Zhang R; Xiang Y; Liu S; Duan T; Lou J; Xie T; Sui X Cancer Biol Med; 2020 Feb; 17(1):60-75. PubMed ID: 32296587 [No Abstract] [Full Text] [Related]
14. Preparation and Wang F; Zhang G; Zang C; Pan H; Ma L; Li C; Hou H; Su P; Gao Y; Sun J; Ye Z J Nanosci Nanotechnol; 2020 Apr; 20(4):2558-2566. PubMed ID: 31492276 [TBL] [Abstract][Full Text] [Related]
15. PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation. Shavi GV; Sreenivasa Reddy M; Raghavendra R; Nayak UY; Kumar AR; Deshpande PB; Udupa N; Behl G; Dave V; Kushwaha K J Liposome Res; 2016; 26(1):28-46. PubMed ID: 25853340 [TBL] [Abstract][Full Text] [Related]
16. PEGylated Lipova E120 liposomes loaded with celecoxib: Dave V; Gupta A; Singh P; Tak K; Sharma S J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502572 [TBL] [Abstract][Full Text] [Related]
17. Preparation, Shen X; Rong W; Adu-Frimpong M; He Q; Li X; Shi F; Ji H; Toreniyazov E; Xia X; Zhang J; Wang Q; Yu J; Xu X Drug Dev Ind Pharm; 2022 Nov; 48(11):623-634. PubMed ID: 36420780 [TBL] [Abstract][Full Text] [Related]
19. Preparation and in vivo safety evaluations of antileukemic homoharringtonine-loaded PEGylated liposomes. Liu D; Xing J; Xiong F; Yang F; Gu N Drug Dev Ind Pharm; 2017 Apr; 43(4):652-660. PubMed ID: 28005445 [TBL] [Abstract][Full Text] [Related]
20. Iron complexation to histone deacetylase inhibitors SAHA and LAQ824 in PEGylated liposomes can considerably improve pharmacokinetics in rats. Wang Y; Tu S; Steffen D; Xiong M J Pharm Pharm Sci; 2014; 17(4):583-602. PubMed ID: 25579435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]